These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25841041)

  • 21. Dose Equivalents for Antipsychotic Drugs: The DDD Method.
    Leucht S; Samara M; Heres S; Davis JM
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S90-4. PubMed ID: 27460622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose response and dose equivalence of antipsychotics.
    Davis JM; Chen N
    J Clin Psychopharmacol; 2004 Apr; 24(2):192-208. PubMed ID: 15206667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.
    Mauri MC; Paletta S; Di Pace C; Reggiori A; Cirnigliaro G; Valli I; Altamura AC
    Clin Pharmacokinet; 2018 Dec; 57(12):1493-1528. PubMed ID: 29915922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.
    Rivière J; van der Mast RC; Vandenberghe J; Van Den Eede F
    Psychosomatics; 2019; 60(1):18-26. PubMed ID: 30181002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight gain and antipsychotics: a drug safety review.
    Musil R; Obermeier M; Russ P; Hamerle M
    Expert Opin Drug Saf; 2015 Jan; 14(1):73-96. PubMed ID: 25400109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.
    Kruse G; Wong BJ; Duh MS; Lefebvre P; Lafeuille MH; Fastenau JM
    Pharmacoeconomics; 2015 Oct; 33(10):1049-67. PubMed ID: 25963579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
    Leucht S; Pitschel-Walz G; Abraham D; Kissling W
    Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Iwata N
    J Psychiatr Res; 2021 Jun; 138():444-452. PubMed ID: 33964682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.
    Leucht S; Wahlbeck K; Hamann J; Kissling W
    Lancet; 2003 May; 361(9369):1581-9. PubMed ID: 12747876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.
    Uguz F
    J Clin Psychopharmacol; 2016 Jun; 36(3):244-52. PubMed ID: 27028982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
    Ng-Mak D; Messali A; Huang A; Wang L; Loebel A
    Am J Manag Care; 2019 Jul; 25(14 Suppl):S279-S286. PubMed ID: 31365818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
    Stauffer V; Ascher-Svanum H; Liu L; Ball T; Conley R
    BMC Psychiatry; 2009 Mar; 9():13. PubMed ID: 19335905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.
    Zhu Y; Krause M; Huhn M; Rothe P; Schneider-Thoma J; Chaimani A; Li C; Davis JM; Leucht S
    Lancet Psychiatry; 2017 Sep; 4(9):694-705. PubMed ID: 28736102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials.
    Wu H; Siafis S; Hamza T; Schneider-Thoma J; Davis JM; Salanti G; Leucht S
    Schizophr Bull; 2022 May; 48(3):643-654. PubMed ID: 35137229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.